Further to the voluntary recall conducted by Fresenius Medical Care on
May 14, 2015, additional lots of NaturaLyte® Sodium Bicarbonate Liquid Concentrate in 6.4L volumes are being recalled due to possible bacterial contamination. Alternative Sodium Bicarbonate Liquid Concentrate has been sourced by Fresenius from other vendors and is available to replace your existing inventory and ensure an uninterrupted supply for your clinic and patients.
This product is used in haemodialysis, which removes waste products from the blood by passing the blood out of the body through a filtering system and returning the cleaned blood to the body when the kidneys are not functioning properly.
The affected product subject to the current recall was distributed to hospitals and home settings between February 23, 2015 and July 15, 2015. Users should check lots (see “Products Affected” section below) prior to administering or using this product.
Products affected
NaturaLyte® Sodium Bicarbonate Liquid Concentrate (DIN:02230083) in 6.4L volume with lots that begin with: 15AMLBxxx, 15BMLBxxx, and 15CMLBxxx.
NaturaLyte® Sodium Bicarbonate Liquid Concentrate (DIN:02230083) in 6.4L and 8L volumes with lots that begin with: 14DMLBxxx, 14EMLBxxx, 14HMLBxxx, 14JMLBxxx, 14KMLBxxx, 14LMLBxxx, 14NMLBxxx, 14PMLBxxx, and 14SMLBxxx were previously recalled on May 14, 2015.
Background information
One lot of NaturaLyte® Sodium Bicarbonate Liquid Concentrate manufactured in 2014 showed elevated bacterial contamination results during ongoing stability shelf life testing. Three different lots were destroyed and never distributed on the market when they exceeded the acceptable level for bacterial contamination. Subsequently, testing of lots manufactured in 2015 indicated that one bottle exceeded the acceptable specification for product release. The affected lot was not distributed in Canada, however the possibility that
other lots manufactured in 2014 and 2015 might also show growth could not be excluded.
The risk of bacteremia is directly related to patient bacterial exposure. Several measures, including the use of the DIASAFEplus® filter or equivalent, and the use of a dialyzer, significantly reduce the risk but do not completely eliminate it.